These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Nephrotic syndrome and immune complex glomerulonephritis associated with chlorpropamide therapy. Appel GB; D'Agati V; Bergman M; Pirani CL Am J Med; 1983 Feb; 74(2):337-42. PubMed ID: 6218754 [TBL] [Abstract][Full Text] [Related]
47. Effect of cyclosporine on in situ immune complex glomerulonephritis. Thaiss F; Mihatsch MJ; Batsford S; Vogt A; Schollmeyer P Clin Nephrol; 1986; 25 Suppl 1():S181-5. PubMed ID: 3519025 [TBL] [Abstract][Full Text] [Related]
48. Induction of an autologous immune complex glomerulonephritis in the rat by intravenous injection of heterologous anti-rat kidney tubular antibody. III. Long-term effects. Barabas AZ; Lannigan R Br J Exp Pathol; 1975 Jun; 56(3):276-9. PubMed ID: 127602 [TBL] [Abstract][Full Text] [Related]
52. Induction of an autologous immune-complex glomerulonephritis in the rat by intravenous injection of heterologous anti-rat kidney tubular antibody IV: Effect of injection of HgCl2 prior to the antibody. Barabas AZ; Alexander F; Lannigan R Br J Exp Pathol; 1976 Oct; 57(5):555-9. PubMed ID: 136979 [TBL] [Abstract][Full Text] [Related]
53. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin. Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066 [TBL] [Abstract][Full Text] [Related]
54. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis? Davenport A; Maciver AG; Hall CL; MacKenzie JC Clin Nephrol; 1994 May; 41(5):271-6. PubMed ID: 8050206 [TBL] [Abstract][Full Text] [Related]
55. The heterologous immune complex glomerulonephritis. A dose dependent glomerulonephritis with acute, latent and chronic phases in a long-term study. Iversen BM; Matre R; Ofstad J Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):241-50. PubMed ID: 6217719 [TBL] [Abstract][Full Text] [Related]
56. Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Tubbs RR; Gephardt GN; McMahon JT; Pohl MC; Vidt DG; Barenberg SA; Valenzuela R Am J Clin Pathol; 1982 Apr; 77(4):409-13. PubMed ID: 7041618 [TBL] [Abstract][Full Text] [Related]
57. [Clinico-morphologic heterogeneity of minimal changes in glomerulonephritis]. Shestakova LA; Varshavskiĭ VA Arkh Patol; 1994; 56(6):22-8. PubMed ID: 7605213 [TBL] [Abstract][Full Text] [Related]
58. An active model of immune complex glomerulonephritis in the rat employing cationized antigen. Oite T; Shimizu F; Kihara I; Batsford SR; Vogt A Am J Pathol; 1983 Aug; 112(2):185-94. PubMed ID: 6224427 [TBL] [Abstract][Full Text] [Related]
59. Idiopathic immune complex glomerulonephritis in dogs with multisystem involvement. Jeraj KP; Vernier RL; Polzin D; Klausner JK; Osborne CA; Stevens JB; Michael AF Am J Vet Res; 1984 Sep; 45(9):1699-705. PubMed ID: 6238560 [TBL] [Abstract][Full Text] [Related]
60. Increased atherosclerosis and glomerulonephritis in cynomolgus monkeys (Macaca fascicularis) given injections of BSA over an extended period of time. Stills HF; Bullock BC; Clarkson TB Am J Pathol; 1983 Nov; 113(2):222-34. PubMed ID: 6227252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]